FBI NGI June 2019 Fact Sheet Statistics:

• The FBI Next Generation Identification (NGI) database 
contains the fingerprints of over 142.6 million individuals 
(both civil and criminal). 
•  Over 98% of the Tenprint Rapsheet Request (TPRS) 
responses were completed within 20 seconds. 

Fiscal Year 2019 Average

In Touch with Your World

FREEDOM TO TRAVEL ABROAD

For the Pharma Technology Industry

FBI fingerprint-based background checks are increasingly required for U.S. Citizens to live, work and travel overseas in many countries such as China, South Korea, Australia, South Africa, Spain and Israel.

Accurate Biometrics was the first authorized FBI Channeler, to provide access to FBI Identity History Summary Checks (IdHS), or Departmental Orders (556-73). For 20 years we have been a leader in the fingerprint industry with our technology capabilities, expertise and dedicated service to government agencies and private industries.

Our expertise will assist your company:

  • Obtain access to Identity History Summary Checks
    for Visa requirements direct from the FBI CJIS
  • National U.S. Collection Network, over 700 locations in 50 states
  • SAME DAY International fingerprint card processing
  • NEW! Accurate Biometrics is the first FBI Channeler approved to 
    provide Cloud Channeling Technology
  • Customized solution-based service to public and private 
    companies to meet their fingerprinting needs

For more information, contact...

Will Peterson 
Director of Business Development
708-887-9258
wpeterson@accuratebiometrics.com
AccurateBiometrics.com

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI